Skip to main content
. Author manuscript; available in PMC: 2022 Feb 24.
Published in final edited form as: Clin Cancer Res. 2022 Feb 15;28(4):708–718. doi: 10.1158/1078-0432.CCR-20-4116

Figure 1.

Figure 1.

Design of the HOPE trial. A, Study schema. B, Consort diagram. This per-patient analysis includes all patients consented for the study regardless of confirmed diagnosis or adequate availability of tissue. Follow-up was performed on all patients when possible to assess clinical attributes that may contribute to successful PDO generation, and 43 patients were still living at last follow-up.